Prescription Drugs | Johnson & johnson remicade infliximab - 100mg ml injection, 100ml
- Supplier Taylor Bell
- Country United States
- Supply Ability 25000 Pieces
- Minimum Order 80 Pieces
Johnson & Johnson Remicade (Infliximab) - 100mg/mL Injection, 100ml Specification: * Active Ingredient: Infliximab (100mg/mL) * Indication: Treatment of moderate-to-severe plaque psoriasis, active ankylosing spondylitis, and Crohn's disease Johnson & Johnson Remicade is a chimeric (mouse-human) monoclonal antibody that works by blocking the activity of tumor necrosis factor-alpha (TNF-alpha), a protein that causes inflammation in the body. It is given by intravenous injection and is used to treat moderate-to-severe plaque psoriasis, active ankylosing spondylitis, and Crohn's disease. Note: The specification section includes the active ingredient, its concentration, and the indication for use. The description section provides additional information about the product and its uses.
